Mitsu Kawa et al. Diabetes 39: 639-642, 1990.* |
Rudinger, In “Peptide Hormones” (ed. J.A. Parsons) University Park Press, Baltimore, pp. 1-7, 1976.* |
Davenport et al., “Somatostatin Type 5 Receptors Mediate the Inhibitory Action of Somatostatin on Insulin Secretion in Zucker Fatty Rat Perfused Pancreas”, Diabetologia (Supp. 1) 38:A106, XP000602793, 1995. |
Moldovan et al., “Somatostatin Inhibits B-Cell Secretion via a Subtype-2 Somatostatin Receptor in the Isolated Perfused Human Pancreas”, J. of Surgical Research 59:85-90, XP000602464, 1995. |
Hoyer et al., “Molecular Pharmacology of Somatostatin Receptors”, Naunyn-Schmiedeberg's Arch Pharmacology 350:441-453, 1994. |
Inoue et al., “Effects of Exogenous Somatostatin and Insulin on Islet Amyloid Polypeptide (Amylin) Release from Perfused Rat Pancreas”, Horm. Metab. Res. 24:251-253, 1992. |
Moore et al., “Co-Secretion of Amylin and Insulin from Cultured Islet Beta-Cells: Modulation By Nutrient Secretagogues, Islet Hormones & Hypoglycemic Agents”, Biochemical & Biophysical Res. Commun. 179:1-9, 1991. |
Rossowski et al., “Specific Inhibition of Rat Pancreatic Insulin or Glucagon Release by Receptor-Selective Somatostatin Analogs”, Biochemical & Biophysical Res. Commun. 205:341-346, 1994. |
Raynor et al., “Cloned Somatostatin Receptors: Identification of Subtype-Selective Peptides and Demonstration of High Affinity Binding of Linear Peptides”, Molecular Pharmacology 43:838-844, 1993. |
Guidobono et al., Peptides, 15 (1994) 699-702. |
Peiro, et al., Life Sciences 49 (1991) 761-765. |
Yamada et al., Biochem. Biophys. Res. Commun. 195 (1993) 844-852. |
Dunmore, et al., J. Endocrinology, 137 (1993) 375-381. |